Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Cardiovascular Devices
Return to: MDBR Home | Specialty Devices | Cardiovascular Devices | News
Search Refinements

Cardiovascular Devices News

View news from other Medical Devices sectors:
1-15 of 2593 results
FDA approves LivaNova’s Memo 4D semi-rigid mitral annuloplasty ring
By MDBR Staff Writer
UK-based medical technology firm LivaNova has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its Memo 4D semi-rigid mitral annuloplasty ring.
Specialty Devices > Cardiovascular Devices > News
CardioNXT, AFTx complete enrollment in RADAR clinical trial
Medical devices firms CardioNXT and AFTx announce that the real-time electrogram analysis for drivers of atrial fibrillation (RADAR) clinical trial has reached full enrollment with 65 treated patients.
Specialty Devices > Cardiovascular Devices > News
Philips to acquire EPD Solutions for EUR250m
By MDBR Staff Writer
Royal Philips has agreed to acquire EPD Solutions, a member of the Hobart Group companies, for an upfront cash consideration of €250m.
Specialty Devices > Cardiovascular Devices > News
TRiCares secures funding for transcatheter-based tricuspid valve replacement system
By MDBR Staff Writer
French medical device start-up firm TRiCares has secured €22m funding to advance the development of its transcatheter-based tricuspid valve replacement system.
Specialty Devices > Cardiovascular Devices > News
Ancora Heart raises $17.8m funding for heart failure therapy
By MDBR Staff Writer
US-based Ancora Heart has raised $17.8m financingto support continued clinical assessment of its AccuCinch ventricular repair system.
Specialty Devices > Cardiovascular Devices > News
Study shows RenalGuard-guided diuretic therapy improves breathing patterns in ADHF patients
By MDBR Staff Writer
RenalGuard Solutions’ clinical trial showed that RenalGuard-guided diuretic therapy has improved breathing patterns and diuretic efficiency in acute decompensated heart failure (ADHF) patients.
Specialty Devices > Cardiovascular Devices > News
Getinge reports positive trends for IABP therapy in SEMPER FI pilot study
By MDBR Staff Writer
Getinge said that its intra-aortic balloon pump (IABP) has shown positive results in a pilot study evaluating the balloon therapy for patients with extensive myocardial infarction (MI or heart attack).
Specialty Devices > Cardiovascular Devices > News
FDA recalls Abbott’s HeartMate 3 due to potential malfunction
By MDBR Staff Writer
The US Food and Drug Administration (FDA) has issued a Class I Recall of Abbott’s HeartMate 3 Left Ventricular Assist System, because of potential malfunction that may lead to graft occlusion.
Specialty Devices > Cardiovascular Devices > News
QT Vascular to divest coronary assets to Teleflex
By MDBR Staff Writer
Singapore-based firm QT Vascular has signed an asset purchase and option agreement (APOA) with US-based Teleflex Life Sciences Unlimited Company and Teleflex for the sale of its intellectual property rights to its non-drug coated coronary products, including Chocolate XD and Glider.
Specialty Devices > Cardiovascular Devices > News
Ultromics secures funding for AI heart diagnostic technology
By MDBR Staff Writer
UK start-up Ultromics has secured £10m funding to advance the commercialization of artificial intelligence (AI) technology for the diagnosis of coronary heart disease.
Specialty Devices > Cardiovascular Devices > News
FDA approves Cerenovus’ Embotrap II revascularization device
By MDBR Staff Writer
Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has secured 510(k) clearance from the US Food and Drug Administration (FDA) for the Embotrap II revascularization device to treat ischemic stroke.
Specialty Devices > Cardiovascular Devices > News
Royal Philips, AHA, UPMC establish venture fund targeting cardiovascular treatment innovations
The American Heart Association (AHA), along with Royal Philips and UPMC, has announced the launch of Cardeation Capital, a $30m collaborative venture capital fund designed to spur healthcare innovation in heart disease and stroke care.
Specialty Devices > Cardiovascular Devices > News
DCP Capital invests in Chinese heart valve developer Venus Medtech
By MDBR Staff Writer
Venus Medtech has secured equity investment from DCP Capital to speed up heart valve technology development and international commercialization.
Specialty Devices > Cardiovascular Devices > News
Ancora Heart expands US feasibility study to evaluate ventricular repair system
Ancora Heart has expanded enrollment of US early feasibility study for the AccuCinch System for left ventricular repair.
Specialty Devices > Cardiovascular Devices > News
Boston Scientific’s data shows Smart Pass sensing filter with Emblem S-ICD reduces shocks in patients
By MDBR Staff Writer
Boston Scientific announced that real-world data showed that Smart Pass sensing filter with Emblem subcutaneous implantable defibrillator (S-ICD) system enabled to reduce the rate of inappropriate shocks in the patients.
Specialty Devices > Cardiovascular Devices > News
1-15 of 2593 results